High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00447356
Recruitment Status : Withdrawn (There were no patient enrolled in this study at this site)
First Posted : March 14, 2007
Last Update Posted : May 13, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Hackensack University Medical Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given